
Sushil Kumar Pandey
About Sushil Kumar Pandey
Data last updated:
Sushil Kumar Pandey is a Director at Scars Pharmaceuticals Private Limited (since 2018). The companies operate in Pharma. Earlier, Sushil Kumar Pandey was a Designated Partner at Medbay Pharma Llp (from 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 Mar 2018 | 2018 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 18 Feb 2021 | 2021 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sushil Kumar Pandey
| Name | DIN | Company | Designation |
|---|---|---|---|
| Atul Kumar Srivastava | 08091949 | Scars Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sushil Kumar Pandey
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sushil Kumar Pandey
Sushil Kumar Pandey currently holds 1 directorship: Scars Pharmaceuticals Private Limited (Director, since 21 Mar 2018).
Sushil Kumar Pandey was first appointed on 21 Mar 2018 as Director at Scars Pharmaceuticals Private Limited. The most recent appointment on record is 18 Feb 2021 at Medbay Pharma Llp.
Sushil Kumar Pandey held 1 earlier board appointment: Medbay Pharma Llp (Designated Partner, from 18 Feb 2021).
The current boards of Sushil Kumar Pandey's companies include Atul Kumar Srivastava (Scars Pharmaceuticals Private Limited).